Cancer’s Embryonic Hijack: HOXD13 & Tumor Advantages
Discover how cancer cells reactivate embryonic programs like HOXD13 to gain selective advantages, revealing new pathways for tumor growth and potential therapeutic targets.
Discover how cancer cells reactivate embryonic programs like HOXD13 to gain selective advantages, revealing new pathways for tumor growth and potential therapeutic targets.